Evidence map›Paper›PMID 36979862›Full record

ArticleBiomedicines2023

Total Chemical Synthesis of LC3A and LC3B Activity-Based Probes.

Yara Huppelschoten, Jens Buchardt, Thomas E Nielsen, Aysegul Sapmaz, Gerbrand J van der Heden van Noort

Open access · goldFull text read
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Yara HuppelschotenDepartment of Cell and Chemical Biology, Leiden University Medical Centre, 2333 ZC Leiden, The Netherlands.
Jens BuchardtNovo Nordisk A/S, Global Research Technologies, Novo Nordisk Park, DK-2760 Måløv, Denmark.
Thomas E NielsenNovo Nordisk A/S, Global Research Technologies, Novo Nordisk Park, DK-2760 Måløv, Denmark.
Aysegul SapmazDepartment of Cell and Chemical Biology, Leiden University Medical Centre, 2333 ZC Leiden, The Netherlands.ORCID 0000-0003-3942-7602
Gerbrand J van der Heden van NoortDepartment of Cell and Chemical Biology, Leiden University Medical Centre, 2333 ZC Leiden, The Netherlands.ORCID 0000-0001-5955-6431
Leiden University · NLNovo Nordisk (Denmark) · DK

Funding

Dutch Research Council VI.192.011
6 · The paper itself

Abstract

Autophagy is a conserved cellular process involved in the degradation of intercellular materials. During this process, double-membrane vesicles called autophagosomes engulf cytoplasmic components ready for degradation. A key component in the formation of autophagosomes are the autophagy-related (Atg) proteins, including microtubule-associated protein light chain 3A (LC3A) and 3B (LC3B). After the C-terminus of LC3 is conjugated to a phospholipid, it promotes the elongation of the phagosome and provides a docking station for the delivery of proteins ready for degradation. Since dysregulation of the autophagy pathway has been associated with a variety of human diseases, components of this process have been considered as potential therapeutic targets. However, the mechanistic details of LC3-specific ligases and deconjugation enzymes are far from unraveled and chemical tools for activity profiling could aid in affording more insights into this process. Herein, we describe a native chemical ligation approach for the synthesis of two LC3 activity-based probes (ABPs). Initial studies show that the probes covalently interact with the cysteine protease ATG4B, showcasing the potential of these probes to unravel mechanistic and structural details.

Indexed as

activity-based probechemical synthesisprotein chemistry

Identifiers

PMID36979862
PMCPMC10045837
OpenAlexW4324151714

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read46
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.